Ireland
--:--IST
Latest
Clinical Trials in South Korea / NCT07505628
Starting soon Not applicable

AI-based Rehabilitation for Hip and Knee Surgery Patients

NCT07505628 · tracked via the Priya Life Science South Korea tracker
Phase
Not applicable
Started
2026-03-09
Last updated
2026-04-01

Condition(s) studied

Total Knee ArthroplastyTotal Hip Arthroplasty (THA)Hip Fracture Surgery

Investigational drug(s) / intervention(s)

Exersite Rehab (AI-based Mobile Application)Printed Educational Brochure (Traditional Rehabilitation)

Exersite Rehab (AI-based Mobile Application): The "Exersite Rehab" is an AI-driven digital healthcare solution designed for post-operative rehabilitation. It utilizes computer vision technology to track the patient's skeletal movements in real-time through a smartphone camera. During the 12-week program, the device provides personalized exercise protocols, real-time posture correction, and automatic repetition counting to ensure safe and effective home-based rehabilitation for patients after hip or knee surgery.

Printed Educational Brochure (Traditional Rehabilitation): Participants in the control group will receive traditional printed educational brochures containing standardized post-operative exercise protocols for hip or knee surgery. These brochures include step-by-step illustrations and written instructions for home-based rehabilitation exercises. Participants are instructed to perform the prescribed exercises independently for 12 weeks, following the same schedule and frequency as the experimental group, but without the AI-based real-time feedback or digital monitoring.

Study summary

This study aims to evaluate the efficacy and safety of an AI-based home rehabilitation application ("Exersite Rehab") for patients who have undergone hip or knee arthroplasty(Total Knee Arthroplasty (TKA), Total Hip Arthroplasty (THA) or hip fracture surgery). Following surgery, effective rehabilitation is crucial for functional recovery; however, many patients face barriers to consistent in-hospital exercise. This interventional study divides participants into two groups to compare outcomes. The experimental group will perform a 12-week home-based rehabilitation program guided by an AI application that provides real-time posture correction and monitoring. In contrast, the control group will perform the same exercise protocol using traditional printed educational brochures.The primary objective is to determine if the AI-based digital healthcare solution significantly improves physical function, measured by the Functional Ambulatory Category(FAC), compared to conventional methods. Secondary outcomes including pain levels(Visual Analog Scale (VAS)) and joint-specific functional scores (Knee Society Score (KSS), Harris Hip Score (HHS)) will also be assessed over the 12-week period.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult patients aged 19 years or older. * Patients scheduled to undergo hip or knee arthroplasty at Gangnam Severance Hospital or affiliated hospitals of Chung-Ang University Medical Center (Chung-Ang University Hospital, Gwangmyeong Hospital, Hyundai Hospital). * Patients with a preoperative Functional Ambulatory Category (FAC) stage of 4 or 5 (For hip fracture cases, pre-fracture FAC stage will be considered). * Patients capable of downloading and using mobile applications on smart devices (smartphones or tablets) independently without researcher assistance. * Patients who fully understand the study's purpose and procedures and have voluntarily signed the informed consent form. Exclusion Criteria: * Individuals unable to perform exercises due to severe musculoskeletal pain. * Individuals with severe dizziness or poor vision that prevents them from following exercise videos provided by the digital treatment. * Individuals with visual impairment that causes difficulty in recognizing the monitor/device screen. * Individuals requiring long-term inpatient treatment due to unstable vital signs. * Individuals with partial or total lower-limb amputation due to trauma, disease, or congenital defects. * Individuals classified as vulnerable subjects (as defined by clinical research ethics guidelines). * Any other individuals deemed ineligible for participation at the discretion of the principal investigator.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Gangnam Severance Hospital Seoul South Korea
Chung-Ang University Hospital Seoul South Korea

More Gangnam Severance Hospital trials in South Korea

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07505628 on ClinicalTrials.gov ↗ ← All trials in South Korea